171 related articles for article (PubMed ID: 33149909)
1. Effect of L-carnitine on health-related quality of life in patients with liver cirrhosis.
Sato S; Namisaki T; Furukawa M; Saikawa S; Kawaratani H; Kaji K; Takaya H; Shimozato N; Sawada Y; Kitagawa K; Moriya K; Akahane T; Mitoro A; Hoki N; Ann T; Yoshiji H
Biomed Rep; 2020 Dec; 13(6):65. PubMed ID: 33149909
[TBL] [Abstract][Full Text] [Related]
2. Carnitine dynamics and their effects on hyperammonemia in cirrhotic Japanese patients.
Shiraki M; Shimizu M; Moriwaki H; Okita K; Koike K
Hepatol Res; 2017 Mar; 47(4):321-327. PubMed ID: 27254133
[TBL] [Abstract][Full Text] [Related]
3. Survival benefit of l-carnitine supplementation in patients with cirrhosis.
Miwa T; Hanai T; Nishimura K; Sakai Y; Imai K; Suetsugu A; Takai K; Shiraki M; Katsumura N; Shimizu M
JPEN J Parenter Enteral Nutr; 2022 Aug; 46(6):1326-1334. PubMed ID: 35511698
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Carnitine Supplementation on Hyperammonemia and Carnitine Deficiency Treated with Valproic Acid in a Psychiatric Setting.
Nakamura M; Nagamine T
Innov Clin Neurosci; 2015; 12(9-10):18-24. PubMed ID: 26634177
[TBL] [Abstract][Full Text] [Related]
5. L-Carnitine for the Treatment of Overt Hepatic Encephalopathy in Patients with Advanced Liver Cirrhosis.
Tajiri K; Futsukaichi Y; Kobayashi S; Yasumura S; Takahara T; Minemura M; Sugiyama T
J Nutr Sci Vitaminol (Tokyo); 2018; 64(5):321-328. PubMed ID: 30381621
[TBL] [Abstract][Full Text] [Related]
6. L-carnitine reduces hospital admissions in patients with hepatic encephalopathy.
Tani J; Morishita A; Sakamoto T; Takuma K; Nakahara M; Fujita K; Oura K; Tadokoro T; Mimura S; Nomura T; Yoneyama H; Kobara H; Himoto T; Masaki T
Eur J Gastroenterol Hepatol; 2021 Feb; 32(2):288-293. PubMed ID: 32925502
[TBL] [Abstract][Full Text] [Related]
7. Effects of L-carnitine supplementation on the quality of life in diabetic patients with muscle cramps.
Imbe A; Tanimoto K; Inaba Y; Sakai S; Shishikura K; Imbe H; Tanimoto Y; Terasaki J; Imagawa A; Hanafusa T
Endocr J; 2018 May; 65(5):521-526. PubMed ID: 29515058
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of Levocarnitine and/or Branched-Chain Amino Acids during Invasive Treatment for Hepatocellular Carcinoma.
Iwasa M; Sugimoto R; Ishihara T; Sekoguchi-Fujikawa N; Yoshikawa K; Mifuji-Moroka R; Tanaka H; Kobayashi Y; Hasegawa H; Takei Y
J Nutr Sci Vitaminol (Tokyo); 2015; 61(6):433-40. PubMed ID: 26875483
[TBL] [Abstract][Full Text] [Related]
9. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
Hamed SA; Abdella MM
Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
[TBL] [Abstract][Full Text] [Related]
10. Quality of life during and between hemodialysis treatments: role of L-carnitine supplementation.
Sloan RS; Kastan B; Rice SI; Sallee CW; Yuenger NJ; Smith B; Ward RA; Brier ME; Golper TA
Am J Kidney Dis; 1998 Aug; 32(2):265-72. PubMed ID: 9708611
[TBL] [Abstract][Full Text] [Related]
11. Can L-carnitine supplementation and exercise improve muscle complications in patients with liver cirrhosis who receive branched-chain amino acid supplementation?
Hiraoka A; Kiguchi D; Ninomiya T; Hirooka M; Abe M; Matsuura B; Hiasa Y; Michitaka K
Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):878-884. PubMed ID: 31150367
[TBL] [Abstract][Full Text] [Related]
12. Effect of L-carnitine on liver enzymes and biochemical factors in hepatic encephalopathy: A systematic review and meta-analysis.
Abbasnezhad A; Choghakhori R; Kashkooli S; Alipour M; Asbaghi O; Mohammadi R
J Gastroenterol Hepatol; 2019 Dec; 34(12):2062-2070. PubMed ID: 31254469
[TBL] [Abstract][Full Text] [Related]
13. The Efficacy of Levocarnitine Treatment in Relieving Fatigue in Patients with Cirrhosis but without Overt Hepatic Encephalopathy.
Abe K; Fujita M; Hayashi M; Takahashi A; Ohira H
Intern Med; 2021; 60(22):3533-3542. PubMed ID: 34776465
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy.
Gramignano G; Lusso MR; Madeddu C; Massa E; Serpe R; Deiana L; Lamonica G; Dessì M; Spiga C; Astara G; Macciò A; Mantovani G
Nutrition; 2006 Feb; 22(2):136-45. PubMed ID: 16459226
[TBL] [Abstract][Full Text] [Related]
15. L-carnitine Reduces Muscle Cramps in Patients With Cirrhosis.
Nakanishi H; Kurosaki M; Tsuchiya K; Nakakuki N; Takada H; Matsuda S; Gondo K; Asano Y; Hattori N; Tamaki N; Suzuki S; Yasui Y; Hosokawa T; Itakura J; Takahashi Y; Izumi N
Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1540-3. PubMed ID: 25496816
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection.
Sato S; Moriya K; Furukawa M; Saikawa S; Namisaki T; Kitade M; Kawaratani H; Kaji K; Takaya H; Shimozato N; Sawada Y; Seki K; Kitagawa K; Akahane T; Mitoro A; Okura Y; Yamao J; Yoshiji H
Clin Mol Hepatol; 2019 Mar; 25(1):65-73. PubMed ID: 30798587
[TBL] [Abstract][Full Text] [Related]
17. Safety, tolerability and symptom outcomes associated with L-carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: a phase I/II study.
Cruciani RA; Dvorkin E; Homel P; Malamud S; Culliney B; Lapin J; Portenoy RK; Esteban-Cruciani N
J Pain Symptom Manage; 2006 Dec; 32(6):551-9. PubMed ID: 17157757
[TBL] [Abstract][Full Text] [Related]
18. [The impact of carnitine on serum ammonia concentration and lipid metabolism in patients with alcoholic liver cirrhosis].
Łapiński TW; Grzeszczuk A
Pol Merkur Lekarski; 2003 Jul; 15(85):38-41. PubMed ID: 14593957
[TBL] [Abstract][Full Text] [Related]
19. L-Carnitine supplementation improved clinical status without changing oxidative stress and lipid profile in women with knee osteoarthritis.
Malek Mahdavi A; Mahdavi R; Kolahi S; Zemestani M; Vatankhah AM
Nutr Res; 2015 Aug; 35(8):707-15. PubMed ID: 26149189
[TBL] [Abstract][Full Text] [Related]
20. The effect of L-carnitine supplementation in 4 pentenoic acid treated rats.
Sugimoto T; Woo M; Nishida N; Araki A; Murakami K; Kobayashi Y
Brain Dev; 1990; 12(4):417-22. PubMed ID: 2240462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
